Arterial Stiffness Intercostal Muscle Oxygenation and Aerobic-Anaerobic Capacity in Elite American Football Players
Investigation of Arterial Stiffness, Intercostal Muscle Oxygenation, Aerobic and Anaerobic Exercise Capacity in Elite American Football Players
1 other identifier
observational
30
1 country
1
Brief Summary
American football has become an increasingly popular sport in Türkiye, and one of the key determinants of success in this discipline is the development of strong aerobic and anaerobic exercise capacities. Previous research has examined arterial stiffness in various athletic populations, including endurance athletes, wrestlers, badminton players, volleyball players, and soccer players. These studies highlight the importance of detailed cardiovascular and hemodynamic evaluation to identify potential risk groups and to better understand sport-specific physiological adaptations. In sports requiring prolonged physical effort, maximal oxygen uptake is a major determinant of performance, underscoring the need to assess this parameter in elite athletic populations. Although a limited number of studies have investigated aerobic and anaerobic exercise capacities in American football athletes, no research to date has evaluated arterial stiffness or intercostal muscle oxygenation in this group. The present study aims to investigate arterial stiffness, intercostal muscle oxygenation, aerobic and anaerobic exercise capacity, and upper-extremity endurance in elite American football players compared with sedentary individuals. A cross-sectional study design will be used. Elite male athletes from the Gazi University American Football Team who volunteer to participate will be included, and their results will be compared with age- and sex-matched sedentary individuals. A total of 15 elite male athletes and 15 sedentary participants aged 18-30 years will be enrolled. All participants will undergo standardized assessments of arterial stiffness, intercostal muscle oxygenation, aerobic and anaerobic capacity, and upper-extremity endurance. Normality of variables will be assessed using visual inspection and the Kolmogorov-Smirnov and Shapiro-Wilk tests. Descriptive statistics will be reported as means, standard deviations, and 95% confidence intervals for normally distributed variables, and medians with interquartile ranges (25th-75th percentiles) for non-normally distributed variables. Frequencies and percentages will be used for categorical data. Between-group comparisons will be conducted using the independent samples t-test for normally distributed variables and the Mann-Whitney U test for non-normally distributed variables. Categorical variables will be analyzed using the chi-square test. A p-value of \<0.05 will be considered statistically significant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedFirst Submitted
Initial submission to the registry
December 8, 2025
CompletedFirst Posted
Study publicly available on registry
January 6, 2026
CompletedJanuary 6, 2026
December 1, 2025
1 year
December 8, 2025
December 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Arterial stiffness
Arterial stiffness was assessed noninvasively using the SphygmoCor XCEL® system (AtCor Medical, Sydney, Australia), a device with established validity and reliability for evaluating central hemodynamic parameters. The device provided measures of aortic systolic blood pressure (SBP), aortic pulse pressure (APP), augmentation pressure (AP), augmentation index (AIx), heart rate-corrected augmentation index (AIx@75), aortic diastolic pressure (DBP), mean arterial pressure (MAP), heart rate (HR), and ejection duration (ED).
First Day
Aortic systolic blood pressure (SBP)
Aortic systolic blood pressure (SBP) was assessed noninvasively using the SphygmoCor XCEL® system (AtCor Medical, Sydney, Australia), a device with established validity and reliability for evaluating central hemodynamic parameters.
First Day
Aortic pulse pressure (APP)
Aortic pulse pressure (APP)was assessed noninvasively using the SphygmoCor XCEL® system (AtCor Medical, Sydney, Australia), a device with established validity and reliability for evaluating central hemodynamic parameters.
First Day
Augmentation pressure (AP)
Augmentation pressure (AP) was assessed noninvasively using the SphygmoCor XCEL® system (AtCor Medical, Sydney, Australia), a device with established validity and reliability for evaluating central hemodynamic parameters.
First Day
Heart rate-corrected augmentation index (AIx@75)
Heart rate-corrected augmentation index (AIx@75) was assessed noninvasively using the SphygmoCor XCEL® system (AtCor Medical, Sydney, Australia), a device with established validity and reliability for evaluating central hemodynamic parameters.
First Day
Aortic diastolic pressure (DBP)
Aortic diastolic pressure (DBP) was assessed noninvasively using the SphygmoCor XCEL® system (AtCor Medical, Sydney, Australia), a device with established validity and reliability for evaluating central hemodynamic parameters.
First Day
Mean arterial pressure (MAP)
Arterial stiffness was assessed noninvasively using the SphygmoCor XCEL® system (AtCor Medical, Sydney, Australia), a device with established validity and reliability for evaluating central hemodynamic parameters.
First Day
Heart rate (HR)
Heart rate (HR) was assessed noninvasively using the SphygmoCor XCEL® system (AtCor Medical, Sydney, Australia), a device with established validity and reliability for evaluating central hemodynamic parameters.
First Day
Ejection duration (ED)
Ejection duration (ED) was assessed noninvasively using the SphygmoCor XCEL® system (AtCor Medical, Sydney, Australia), a device with established validity and reliability for evaluating central hemodynamic parameters.
First Day
Muscle oxygenation
Muscle oxygenation was assessed using the Moxy® Monitor (Fortiori Design LLC, Minnesota, USA), a small, lightweight, and wireless near-infrared spectroscopy (NIRS) device that measures local muscle oxygen saturation (SmO₂) and total hemoglobin (THb) in the capillary bed of the underlying muscle tissue.
First Day
Aerobic exercise capacity
Maximal exercise capacity was evaluated using the ISWT, a standardized, externally paced, symptom-limited field test that progressively increases walking speed at one-minute intervals.
First day
Secondary Outcomes (2)
Anaerobic exercise capacity
First day
Anaerobic power
First day
Study Arms (2)
Elite male American football players
Demographic characteristics were recorded. Inclusion criteria for the elite American football group were being a male athlete aged 18-30 years and volunteering to participate. Exclusion criteria included having any acute infection, orthopedic, neurological, or sensory problems (hearing, vision, or cooperation difficulties) that could interfere with measurements, a history of smoking, alcohol consumption, or COVID-19 infection, and use of medications or antioxidant supplements. Aerobic exercise capacity was evaluated using the Incremental Shuttle Walking Test (ISWT), anaerobic exercise capacity with the Vertical Jump Test, arterial stiffness using the SphygmoCor® XCEL Pulse Wave Analysis (PWA) Arteriograph, and intercostal muscle oxygenation by the Moxy® Muscle Oxygen Monitor.
Health Controls
Demographic characteristics were recorded. The sedentary group (sedentary individuals were defined as those engaging in less than 150 minutes per week of moderate-intensity physical activity or its equivalent, according to WHO guidelines, inclusion criteria were being a male aged 18-30 years and volunteering to participate, while exclusion criteria included any acute, orthopedic, neurological, or sensory condition that might interfere with the assessments, as well as having a regular exercise habit. Aerobic exercise capacity was evaluated using Incremental Shuttle Walking Test (ISWT), anaerobic exercise capacity with the Vertical Jump Test, arterial stiffness using the SphygmoCor® XCEL Pulse Wave Analysis (PWA) Arteriograph, and intercostal muscle oxygenation by the Moxy® Muscle Oxygen Monitor.
Eligibility Criteria
Thirty participants, including 15 American football players and 15 healthy controls, were evaluated.
You may qualify if:
- Being a male athlete aged 18-30 years
- Volunteering to participate
You may not qualify if:
- Having any acute infection, orthopedic, neurological, or sensory problems (hearing, vision, or cooperation difficulties) that could interfere with measurements
- A history of smoking
- A history of alcohol consumption
- A history of COVID-19 infection
- Use of medications or antioxidant supplements
- Being a male aged 18-30 years
- Volunteering to participate
- Included any acute, orthopedic, neurological, or sensory condition that might interfere with the assessments
- Having a regular exercise habit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University Faculty of Health Sciences Department of Cardiopulmonary Physiotherapy and Rehabilitation, Ankara, Çankaya 06490
Ankara, Çankaya, 06490, Turkey (Türkiye)
Related Publications (7)
Ross A, Leveritt M. Long-term metabolic and skeletal muscle adaptations to short-sprint training: implications for sprint training and tapering. Sports Med. 2001;31(15):1063-82. doi: 10.2165/00007256-200131150-00003.
PMID: 11735686RESULTMayorga-Vega D, Aguilar-Soto P, Viciana J. Criterion-Related Validity of the 20-M Shuttle Run Test for Estimating Cardiorespiratory Fitness: A Meta-Analysis. J Sports Sci Med. 2015 Aug 11;14(3):536-47. eCollection 2015 Sep.
PMID: 26336340RESULTAllen TW, Vogel RA, Lincoln AE, Dunn RE, Tucker AM. Body size, body composition, and cardiovascular disease risk factors in NFL players. Phys Sportsmed. 2010 Apr;38(1):21-7. doi: 10.3810/psm.2010.04.1758.
PMID: 20424398RESULTBangsbo J, Mohr M, Krustrup P. Physical and metabolic demands of training and match-play in the elite football player. J Sports Sci. 2006 Jul;24(7):665-74. doi: 10.1080/02640410500482529.
PMID: 16766496RESULTPerrey S, Quaresima V, Ferrari M. Muscle Oximetry in Sports Science: An Updated Systematic Review. Sports Med. 2024 Apr;54(4):975-996. doi: 10.1007/s40279-023-01987-x. Epub 2024 Feb 12.
PMID: 38345731RESULTAshor AW, Lara J, Siervo M, Celis-Morales C, Mathers JC. Effects of exercise modalities on arterial stiffness and wave reflection: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2014 Oct 15;9(10):e110034. doi: 10.1371/journal.pone.0110034. eCollection 2014.
PMID: 25333969RESULTKresnajati S, Lin YY, Mundel T, Bernard JR, Lin HF, Liao YH. Changes in Arterial Stiffness in Response to Various Types of Exercise Modalities: A Narrative Review on Physiological and Endothelial Senescence Perspectives. Cells. 2022 Nov 9;11(22):3544. doi: 10.3390/cells11223544.
PMID: 36428973RESULT
Study Officials
- STUDY CHAIR
Betül Yoleri, MSc
Gazi University
- STUDY DIRECTOR
Meral Boşnak Güçlü, Prof
Gazi University
- PRINCIPAL INVESTIGATOR
Neslişah Tunçay, Pt
Gazi University
- PRINCIPAL INVESTIGATOR
Aleyna Gökdeniz, Pt
Gazi University
- PRINCIPAL INVESTIGATOR
Bünyamin Ertuş, Pt
Gazi University
- PRINCIPAL INVESTIGATOR
Esin Yağmur Kart, Pt
Gazi University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
December 8, 2025
First Posted
January 6, 2026
Study Start
June 1, 2024
Primary Completion
June 1, 2025
Study Completion
July 1, 2025
Last Updated
January 6, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share